Transcriptome analysis in oncology and dermatology
- Authors: Sergeeva E.Y.1, Fefelova Y.A.1, Bardezkaya Y.V.1
-
Affiliations:
- Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
- Issue: Vol 20, No 1 (2022)
- Pages: 3-8
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113544
- DOI: https://doi.org/10.29296/24999490-2022-01-01
- ID: 113544
Cite item
Abstract
Personalized therapy allows to reveal subtypes of diseases with similar symptoms but various molecular mechanisms of development. Different -omics (genomics, epigenomics, transcriptomics, proteomics ets) are used to divide the diseases into subtypes. Transcriptomics is the investigation of whole RNA profile coding by the genome of single cell in specific time period or under specific circumstances. Transcriptome is all RNA transcripts produced by the genome in some time. The aim of the review is to summarize the modern data on perspective methods of investigation - microarray and next generation sequencing (NGS), to disclose the advantages and peculiarities of every method and the use in dermatology and oncology. Material and methods. The materials are the results of the investigations on the theme of russian and foreign researchers and ours published data over the past 13 years, from 2007 till 2020. The data was obtained from biomedical on-line databases PubMed, EMBASE, MedLine. Results. Modern data on microarray and next generation sequencing in the context of transcriptome investigations are summarized in the article. The choice of method is based on the peculiarities and tasks of the investigation. Recently transcriptome investigations are used in many medicine fields including oncology and dermatology that promotes the development of personalized therapy and precise prognosis of diseases. Conclusion. Transcriptome investigations allow to assess the alterations of gene expression profile after the influence of etiologic factors that extends the understanding of diseases pathogenesis and leads to the increased effectivity of therapy
Keywords
Full Text
About the authors
Ekaterina Yurievna Sergeeva
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: e.yu.sergeeva@mail.ru
professor of the Department of pathological physiology.
Yulia Anotolievna Fefelova
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: fefelovaja@mail.ru
associated professor of the Department of pathological physiology.
Yaroslavna Vladimirovna Bardezkaya
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Author for correspondence.
Email: byvkgpu@yandex.ru
associated professor of the Department of pathological physiology
References
- Рукша Т.Г., Аксененко М.Б., Сергеева Е.Ю., Фефелова Ю.А. Меланома кожи: от системной биологии к персонифицированной терапии. Вестник дерматологии и венерологии. 2013; 1: 4-8.
- Aldridge S., Teichmann S.A. Single cell transcriptomics comes of age. Nat. Commun. 2020; 11 (1): 4307. https://doi.org/10.1038/s41467-020-18158-5
- Chu C., Fang Z., Hua X., Yang Y., Chen E., Cowley A.W. Jr., Liang M., Liu P., Lu Y. deGPS is a powerful tool for detecting differential expression in RNA-sequencing studies. BMC Genomics. 2015; 16 (1): 455. https://doi.org/10.1186/s12864-015-1676-0
- Royce T.E., Rozowsky J.S., Gerstein M.B. Toward a universal microarray: prediction of gene expression through nearest-neighbor probe sequence identification. Nucleic Acids Res. 2007; 35 (15): e99. https://doi.org/10.1093/nar/gkm549
- Wang Z., Gerstein M., Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev Genet. 2009; 10 (1): 57-63. https://doi.org/10.1038/nrg2484
- Yousef M., Kumar A., Bakir-Gungor B. Application of biological domain knowledge based feature selection on gene expression data. Entropy (Basel). 2020; 23 (1): 2. https://doi.org/10.3390/e23010002
- Perscheid C., Grasnick B., Uflacker M. Integrative gene selection on gene expression data: providing biological context to traditional approaches. J. Integr. Bioin form. 2018; 16 (1): 20180064. https://doi.org/10.1515/jib-2018-0064
- Pinero J., Bravo Ä., Queralt-Rosinach N., Gutierrez-Sacristan A., Deu-Pons J., Centeno E., Garcia-Garcia J., Sanz F., Furlong L.I. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017; 45 (D1): 833-9. https://doi.org/10.1093/nar/gkw943
- Cloonan N., Forrest A.R., Kolle G., Gardiner B.B., Faulkner G.J., Brown M.K., Taylor D.F., Steptoe A.L., Wani S., Bethel G., Robertson A.J., Perkins A.C., Bruce S.J., Lee C.C., Ranade S.S., Peckham H.E., Manning J.M., McKernan K.J., Grimmond S.M. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat. Methods. 2008; 5 (7): 613-9. https://doi.org/10.1038/nmeth.1223
- Nagalakshmi U., Wang Z., Waern K., Shou C., Raha D., Gerstein M., Snyder M. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science. 2008; 320 (5881): 1344-9. https://doi.org/10.1126/science.1158441
- Song Y., Xu X., Wang W., Tian T., Zhu Z., Yang C. Single cell transcriptomics: moving towards multi-omics. Analyst. 2019; 144 (10): 3172-89. https://doi.org/10.1039/c8an01852a
- Tokura Y., Hayano S. Subtypes of atopic dermatitis: From phenotype to endotype. Allergol. Int. 2021; S1323-8930(21)00079-4. https://doi.org/10.10Wj.alit.2021.07.003
- Tao Z., Shi A., Li R., Wang Y., Wang X., Zhao J. Microarray bioinformatics in cancer- a review. J. BUON. 2017; 22 (4): 838-43.
- Stark R., Grzelak M., Hadfield J. RNA sequencing: the teenage years. Nat. Rev Genet. 2019; 20 (11): 631-56. https://doi.org/10.1038/s41576-019-0150-2
- Efremova M., Teichmann S.A. Computational methods for single-cell omics across modalities. Nat. Methods. 2020; 17 (1): 14-7. https://doi.org/10.1038/s41592-019-0692-4
- Аксененко М.Б., Комина А.В., Палкина Н.В., Аверчук А.С., Рыбников Ю.А., Дыхно Ю.А., Рукша Т.Г. Транскриптомный анализ клеток меланомы, полученных из различных участков первичной опухоли. Сибирский онкологический журнал. 2018; 17 (4): 59-66. https://doi.org/10.21294/1814-4861-2018-17-4-59-66
- Hoek K.S., Eichhoff O.M., Schlegel N.C., Dö-bbeling U., Kobert N., Schaerer L., Hemmi S., Dummer R. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 2008; 68 (3): 650-6. https://doi.org/10.1158/0008-5472. CAN-07-2491
- Kim K., Park S., Park S.Y., Kim G., Park S.M., Cho J.W., Kim D.H., Park Y.M., Koh Y.W., Kim H.R., Ha S.J., Lee I. Single-cell transcriptome analysis reveals TOX as a promoting factor for T. cell exhaustion and a predictor for anti-PD-1 responses in human cancer. Genome Med. 2020; 12 (1): 22. https://doi.org/10.1186/s13073-020-00722-9
- Marie K.L., Sassano A., Yang H.H., Michalowski A.M., Michael H.T., Guo T., Tsai Y.C., Weissman A.M., Lee M.P., Jenkins L.M., Zaidi M.R., Perez-Guijarro E., Day C.P., Ylaya K., Hewitt S.M., Patel N.L., Arnheiter H., Davis S., Meltzer P.S., Merlino G., Mishra P.J. Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis. Nat. Commun. 2020; 11 (1): 333. https://doi.org/10.1038/s41467-019-14085-2
- Рукша Т.Г., Прохоренков В.И., Салмина А.Б., Петрова Л.Л., Труфанова Л.В. Современные представления об этиологии и патогенезе меланомы кожи. Вестник дерматологии и венерологии. 2007; 5: 22-8.
- Gyrylova S.N., Aksenenko M.B., Gavrilyuk D.V., Palkina N.V., Dyhno Y.A., Ruksha T.G., Artyukhov I.P. Melanoma incidence mortality rates and clinico-pathological types in the Siberian area of the Russian Federation. Asian Pac. J. Cancer Prev. 2014; 15 (5): 2201-4. https://doi.org/10.7314/ap-jcp.2014.15.5.2201
- Aksenenko M.B., Kirichenko A.K., Ruksha T.G. Russian study of morphological prognostic factors characterization in BRAF-mutant cutaneous melanoma. Pathol. Res. Pract. 2015; 211 (7): 521-7. https://doi.org/10.1016/j.prp.2015.03.005
- Chen W., Cheng P., Jiang J., Ren Y., Wu D., Xue D. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma. Aging (Albany NY). 2020; 12 (13): 12703-25. https://doi.org/10.18632/aging.103115
- Grasso C.S., Tsoi J., Onyshchenko M., Abril-Rodriguez G., Ross-Macdonald P., Wind-Rotolo M., Champhekar A., Medina E., Torrejon D.Y., Shin D.S., Tran P., Kim Y.J., Puig-Saus C., Campbell K., Vega-Crespo A., Quist M., Martignier C., Luke J.J., Wolchok J.D., Johnson D.B., Chmielowski B., Hodi F.S., Bhatia S., Sharfman W., Urba W.J., Slingluff C.L. Jr., Diab A., Haanen J.B.A.G., Algarra S.M., Pardoll D.M., Anagnostou V., Topalian S.L., Velculescu V.E., Speiser D.E., Kalbasi A., Ribas A. Conserved interferon-γ signaling drives clinical response to immune checkpoint blockade therapy in melanoma. Cancer Cell. 2020; 38 (4): 500-15. e3. https://doi.org/10.10Wj.ccell.2020.08.005
- Riaz N., Havel J.J., Makarov V., Desrichard A., Urba W.J., Sims J.S., Hodi F.S., Martin-Algarra S., Mandal R., Sharfman W.H., Bhatia S., Hwu W.J., Gajewski T.F., Slingluff C.L. Jr., Chowell D., Kendall S.M., Chang H., Shah R., Kuo F., Morris L.G.T., Sidhom J.W., Schneck J.P., Horak C.E., Weinhold N., Chan T.A. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell. 2017; 171 (4): 934-49. e16. https://doi.org/10.1016/j.cell.2017.09.028
- Pu M., Messer K., Davies S.R., Vickery T.L., Pittman E., Parker B.A., Ellis M.J., Flatt S.W., Marinac C.R., Nelson S.H., Mardis E.R., Pierce J.P., Natarajan L. Research-based PAM50 signature and long-term breast cancer survival. Breast Cancer Res. Treat. 2020; 179 (1): 197-206. https://doi.org/10.1007/s10549-019-05446-y
- Wang L., Wang Y., Su B., Yu P., He J., Meng L., Xiao Q., Sun J., Zhou K., Xue Y., Tan J. Transcriptome-wide analysis and modelling of prognostic alternative splicing signatures in invasive breast cancer: a prospective clinical study Sci. Rep. 2020; 10 (1): 16504. https://doi.org/10.1038/s41598-020-73700-1
- Lin Q.G., Liu W., Mo Y.Z., Han J., Guo Z.X., Zheng W., Wang J.W., Zou X.B., Li A.H., Han F. Development of prognostic index based on autophagy-related genes analysis in breast cancer. Aging (Albany NY). 2020; 12 (2): 1366-76. https://doi.org/10.18632/ag-ing.102687
- Bell R., Barraclough R., Vasieva O. Gene expression meta-analysis of potential metastatic breast cancer markers. Curr, Mol. Med. 2017; 17 (3): 200-10. https://doi.org/10.2174/1566524017666170807144946
- Рукша Т.Г., Аксененко М.Б., Климина Г.М., Новикова Л.В. Внеклеточный матрикс кожи: роль в развитии дерматологических заболеваний. Вестник дерматологии и венерологии. 2013; 89 (6): 32-9.
- Swindell W.R., Johnston A., Voorhees J.J., Elder J.T., Gudjonsson J.E. Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients. BMC Genomics. 2013; 14: 527. https://doi.org/10.1186/1471-2164-14-527
- Swindell W.R., Johnston A., Xing X., Voorhees J.J., Elder J.T., Gudjonsson J.E. Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation. PLoS One. 2013; 8 (11): e79253. https://doi.org/10.1371/journal.pone.0079253
- Zeng X., Zhao J., Wu X., Shi H., Liu W., Cui B., Yang L., Ding X., Song P. PageRank analysis reveals topologically expressed genes correspond to psoriasis and their functions are associated with apoptosis resistance. Mol. Med. Rep. 2016; 13 (5): 3969-76. https://doi.org/10.3892/mmr.2016.4999
- Lambert S., Hambro C.A., Johnston A., Stuart P.E., Tsoi L.C., Nair R.P., Elder J.T. Neutrophil extracellular traps induce human Th17 cells: effect of psoriasis-associated TRAF3IP2 genotype. J. Invest. Dermatol. 2019; 139 (6): 1245 53. https://doi.org/10.1016/jjid.2018.11.021
- Martel B.C., Litman T., Hald A., Norsgaard H., Lovato P., Dyring-Andersen B., Skov L., Thestrup-Pedersen K., Skov S., Skak K., Poulsen L.K. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Exp. Dermatol. 2016; 25 (6): 453-9. https://doi.org/10.1111/exd.12967
- Brown S.J. Molecular mechanisms in atopic eczema: insights gained from genetic studies. J. Pathol. 2017; 241 (2): 140-5. https://doi.org/10.1002/path.4810
- Tham E.H., Dyjack N., Kim B.E., Rios C., Seibold M.A., Leung D.Y.M., Goleva E. Expression and function of the ectopic olfactory receptor OR10G7 in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2019; 143 (5): 1838-1848. e4. https://doi.org/10.1016/j.jaci.2018.11.004
- Meng J., Moriyama M., Feld M., Buddenkotte J., Buhl T., Szöllösi A., Zhang J., Miller P., Ghetti A., Fischer M., Reeh P.W., Shan C., Wang J., Steinhoff M. New mechanism underlying IL-31-induced atopic dermatitis. J. Allergy Clin. Immunol. 2018; 141 (5): 1677-89. e8. https://doi.org/10.10Wj.jaci.2017.12.1002